M&A Deal Summary

Hologic Acquires Mobidiag

On April 8, 2021, Hologic acquired life science company Mobidiag from Autobio Diagnostics for 795M USD

Acquisition Highlights
  • This is Hologic’s 4th transaction in the Life Science sector.
  • This is Hologic’s 4th largest (disclosed) transaction.
  • This is Hologic’s 1st transaction in Finland.

M&A Deal Summary
Date 2021-04-08
Target Mobidiag
Sector Life Science
Buyer(s) Hologic
Sellers(s) Autobio Diagnostics
Deal Type Divestiture
Deal Value 795M USD

Target

Mobidiag

Espoo, Finland
Mobidiag is a biotech company specializing in rapid diagnostics of infectious diseases. The company develops and sells fast and accurate molecular diagnostic assays for the diagnosis of pathogenic microbes causing severe infections. Mobidiag was founded in 2000 and is based in Espoo, Finland.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hologic

Marlborough, Massachusetts, United States
Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.0B USD (2023)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 22 of 24
Sector (Life Science) 4 of 4
Type (Divestiture) 2 of 2
Country (Finland) 1 of 1
Year (2021) 4 of 5
Size (of disclosed) 4 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-01 Diagenode S.A.

Denville, New Jersey, United States

Diagenode S.A. is a developer and manufacturer of molecular diagnostic assays and epigenetics products. Diagenode offers more than 30 real-time PCR (polymerase chain reaction) tests that are CE-marked for the detection of bacteria, parasites and viruses involved in sexually transmitted infections, respiratory diseases, meningitis and gastroenteritis. Diagenode was founded in 2003 and is based in Denville, New Jersey.

Buy $159M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-14 Bolder Surgical

Louisville, Colorado, United States

Bolder Surgical is a developer and producer of precisely designed surgical instruments that allow access to confined structures found in pediatric and other surgical procedures. Bolder Surgical was founded in 2010 and is based in Louisville, Colorado.

Buy $160M

Seller(S) 1

SELLER

Autobio Diagnostics

Zhengzhou, China
Category Company
Founded 1998
Sector Life Science
Employees5,539
Revenue 4.4B CNY (2023)
DESCRIPTION

Autobio Diagnostics is specialized in the research & development, production, marketing, and service of clinical diagnostic products, including immunoassay, microbiology, and biochemical products. Autobio provides comprehensive solutions for medical laboratories. Autobio Diagnostics Co. was incorporated in 1998 and is headquartered in Zhengzhou, China.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Finland) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-17 Mobidiag

Espoo, Finland

Mobidiag is a biotech company specializing in rapid diagnostics of infectious diseases. The company develops and sells fast and accurate molecular diagnostic assays for the diagnosis of pathogenic microbes causing severe infections. Mobidiag was founded in 2000 and is based in Espoo, Finland.

Buy -
Mergr

Product

Company

Legal